Local expression of ε germline gene transcripts and RNA for the ε heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 4, 2001, Pages 686-692

  Ying, Sun ^a   Humbert, Marc ^a   Meng, Qiu ^a   Pfister, Rudi ^c   Menz, Gunter ^c   Gould, Hannah J ^b   Kay, A Barry ^a   Durham, Stephen R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Hochgebirgsklinik   (United Kingdom)

Author keywords

Atopic asthma; IL 4; Local IgE; Nonatopic asthma

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 4; MESSENGER RNA;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS; FEMALE; GENETICS; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MUCOSA; ALLERGIC ASTHMA; ALLERGIC RHINITIS; B LYMPHOCYTE; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; FIBEROPTIC BRONCHOSCOPY; GENE EXPRESSION; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NOSE MUCOSA; PRIORITY JOURNAL;

ADULT; AGED; ASTHMA; BRONCHI; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN HEAVY CHAINS; INTERLEUKIN-4; MALE; MIDDLE AGED; MUCOUS MEMBRANE; RNA, MESSENGER;

EID: 0034744489     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.114339     Document Type: Article

References (42)

1. Mechanism and regulation of immunoglobulin isotype switching
2. Interleukin 4 is localized to and released by human mast cells
3. IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression
4. Role of type I and type 2 T helper cells in allergic diseases
5. Induction of human IgE synthesis in B cells by mast cells and basophils
6. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand cytokines and antibody production delineates sites of cognate T-B cell interactions
7. Expression of ε germ-line transcripts and mRNA for the ε heavy chain of IgE in nasal B cells and the effects of topical corticosteroid
8. Expression of IL-4 Cε RNA and Iε RNA in the nasal mucosa of patients with seasonal rhinitis: Effect of topical corticosteroids
9. Expression of IgE heavy chain transcripts in the sinus mucosa of atopic and non-atopic patients with chronic sinusitis
10. IL-4 and IL-5 mRNA and protein in bronchial biopsies from atopic and non-atopic asthmatics: Evidence against "intrinsic" asthma being a distinct immunopathological entity
11. Safety of fibreoptic bronchoscopy in asthmatics and control subjects and effect on asthma control over two weeks
12. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
13. Expression of mRNA for interleukin-5 in mucosa bronchial biopsies from asthma
14. Topical glucocorticosteroid (fluticasone propionate) inhibits cytnkine mRNA expression for interleukin-4 (IL-4) in the nasal mucosa in allergic rhinitis
15. T lymphocytes and mast cells express messenger RNA for the interleukin-4 in the nasal mucosa in allergen-induced rhinitis
16. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter
17. Cloning and sequence determination of the gene for the human immunoglobulin epsilon chain expressed in a myeloma cell line
18. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies
19. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
20. Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma
21. Eosinophils T-lymphocytes mast cells neutrophils and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
22. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study
23. Intrasubject variability in airway inflammation in biopsies in mild to moderate stable asthma
24. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge
25. Where do mast cells acquire IgE?
26. Local IgE antibodies in allergic rhinitis
27. Measurement of specific IgE antibodies in nasal secretion - Evidence for local production
28. Local production of IgG IgA and IgE antibodies in grass pollen hay fever
29. Changes in nasal specific IgE to mites after periods of allergen exposure-avoidance: A comparison with serum levels
30. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms
31. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern
32. A working classification of asthma
33. Extrinsic and intrinsic asthma: Still a matter for debate?
34. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults
35. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: More similarities than differences
36. Identification of T-lymphocytes macrophages and activated eosinophils in the bronchial mucosa in intrinsic asthma: Relationship to symptoms and bronchial responsiveness
37. Bronchial mucosa expression of the CC chemokine genes RANTES and MCP-3 in symptomatic atopic and non-atopic asthmatics: Relationship to EG2+ eosinophils and the eosinophil-active cytokines IL-5 GM-CSF and IL-3
38. High affinity IgE receptor (FcεRI)-bearing cells in bronchial biopsies from atopic and non-atopic asthma
39. The effect of an anti-IgE monoclonal antibody on the early and late phase responses to allergen inhalation in asthmatic subjects
40. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response
41. Treatment of allergic asthma with monoclonal anti-IgE antibody